Sh Pharmaceutical reported 5.01B in EBITDA for its fiscal quarter ending in June of 2025.


Ebitda Change Date
Cspc Pharmaceutical CNY 2.19B 21.88M Dec/2024
Jiangsu Hengrui 2.98B 890.87M Jun/2025
Sh Fosun Pharma 1.69B 17.13M Jun/2025
Sino Biopharmaceutical CNY 2.59B 1.57B Dec/2024
WuXi AppTec 5.71B 1.36B Jun/2025